RA CAPITAL MANAGEMENT, L.P. - 14 Dec 2022 Form 4 Insider Report for Fulcrum Therapeutics, Inc. (FULC)

Role
10%+ Owner
Signature
/s/ Peter Kolchinsky, Manager of RA Capital Management, L.P.
Issuer symbol
FULC
Transactions as of
14 Dec 2022
Net transactions value
+$13,073,874
Form type
4
Filing time
16 Dec 2022, 15:41:46 UTC
Previous filing
15 Dec 2022
Next filing
21 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FULC Common Stock Purchase $4,501,574 +824,600 +12% $5.46 7,824,600 14 Dec 2022 See Footnotes F1, F6
transaction FULC Common Stock Purchase $1,302,474 +237,029 +3% $5.50 8,061,629 15 Dec 2022 See Footnotes F2, F3, F6
transaction FULC Common Stock Purchase $7,269,826 +1,341,420 +17% $5.42 9,403,049 16 Dec 2022 See Footnotes F4, F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Held directly by RA Capital Healthcare Fund, L.P. (the "Fund").
F2 This transaction was executed in multiple trades at prices ranging from $5.35 to $5.50; the price reported above reflects the weighted average purchase price. The reporting person hereby undertakes, upon request, to provide full information to the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer regarding the number of shares and prices at which these transactions, and all other transactions reported in this Form 4, were effected.
F3 Held directly by the Fund.
F4 This transaction was executed in multiple trades at prices ranging from $5.25 to $5.69; the price reported above reflects the weighted average purchase price. The reporting person hereby undertakes, upon request, to provide full information to the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer regarding the number of shares and prices at which these transactions, and all other transactions reported in this Form 4, were effected.
F5 Held directly by the Fund.
F6 RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund. The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.